The aim of the present study was to analyze the risk features and to discuss the preventive measures and treatment of stomal recurrence (SR) after total laryngectomy (TL), and to investigate the clonal relationship between the primary and recurrent lesions. We reviewed a series of 25 patients affected by SR after TL for laryngeal squamous cell carcinoma. A subset of 7 coupled primary and recurrent carcinomas were examined for microsatellite alterations that were used as a marker of genetic lineage. The incidence of SR was higher in patients with initial subglottic lesions (subglottic, transglottic, or glottic-subglottic tumors) than in those with other locations of laryngeal cancer (p = .013). In addition, the frequency of SR was significantly higher in patients who underwent preoperative tracheotomy, performed 48 hours or more before the TL, than in the group of patients who did not receive preoperative tracheotomy (23.3% versus 0.46%, p < .001). According to microsatellite analysis, of the 5 informative patients, 2 demonstrated discordant alterations in the recurrent tumor indicative of clonal heterogeneity, 2 demonstrated identical alterations, and 1 showed an additional alteration in the recurrent tumor. Our analysis supports the hypothesis that a subset of SRs after TL may be second primary tumors, genetically unrelated to the primary laryngeal lesion.
LeònXQuerMBurguèsJAbellòPVegaMde AndrèsL. Prevention of stomal recurrence. Head Neck1996; 18: 54–9.
2.
KiemWFShapiroMJRosinHD. Study of postlaryngectomy stoma recurrence. Arch Otolaryngol1965; 81: 183–6.
3.
De JongPC. Intubation and tumor implantation in laryngeal carcinoma. Pract Otorhinolaryngol1969; 31: 1119–21.
4.
BatsakisJGHybelsRRiceDH. Laryngeal carcinoma: stomal recurrences and distant metastases. Centennial Conference on Laryngeal Cancer, Toronto. New York, NY: Appleton-Century-Crofts, 1974: 868–76.
5.
BonneauRALehmanRH. Stomal recurrence following laryngectomy. Arch Otolaryngol1975; 101: 408–12.
6.
WeberRSMarvelJSmithPHankinsPWolfPGoepfertH. Paratracheal lymph node dissection for carcinoma of the larynx, hypopharynx, and cervical esophagus. Otolaryngol Head Neck Surg1993; 108: 11–7.
7.
HarrisonDFN. The pathology and management of subglottic cancer. Ann Otol Rhinol Laryngol1971; 80: 6–12.
8.
RubinJJohnsonJTMyersEN. Stomal recurrence after laryngectomy: Interrelated risk factor study. Otolaryngol Head Neck Surg1990; 103: 805–12.
9.
BrenemanJCBradshawAGluckmanJAronBS. Prevention of stomal recurrence in patients requiring emergency tracheostomy for advanced laryngeal and pharyngeal tumors. Cancer1988; 62: 802–5.
10.
HosalINOnerciMTuranE. Peristomal recurrence. Am J Otolaryngol1993; 14: 206–8.
EstebanFMorenoJADelgado-RodrìguezMMochonA. Risk factors involved in stomal recurrence following laryngectomy. J Laryngol Otol1993; 107: 527–31.
14.
StellPMvan den BroekP. Stomal recurrence after laryngectomy: Aetiology and management. J Laryngol Otol1971; 85: 131–40.
15.
SissonGABytellDEEdisonBDYehSJr. Transsternal radical neck dissection for control of stomal recurrences — End results. Laryngoscope1975; 85: 1504–10.
16.
SchneiderJJLindbergRDJesseRH. Prevention of tracheal stoma recurrences after total laryngectomy by postoperative irradiation. J Surg Oncol1975; 7: 187–90.
17.
TongDMossWTStevensKRJr. Elective irradiation of the lower cervical region in patients at high risk for recurrent cancer at the tracheal stoma. Radiology1977; 124: 809–11.
18.
WeismanRAColmanMWardPH. Stomal recurrence following laryngectomy: A critical evaluation. Ann Otol Rhinol Laryngol1979; 88: 855–60.
19.
GriebieMSAdamsGL. “Emergency” laryngectomy and stomal recurrence. Laryngoscope1987; 97: 1020–4.
20.
ZhangLEpsteinJBandP. Local tumor recurrence or emergence of a new primary lesion? A molecular analysis. J Oral Pathol Med1999; 28: 381–4.
21.
van OijenMGCTLeppersVDStraatFGJTilanusMGJSlootwegPJ. The origins of multiple squamous cell carcinomas in the aerodigestive tract. Cancer2000; 88: 884–93.
22.
ParsonsRLiGMLongleyM. Mismatch repair deficiency in phenotypically normal human cells. Science1995; 268: 738–40.
23.
Kumar-SinghRWangHHumphriesPFarrarGJ. Autosomal dominant retinitis pigmentosa: No evidence for nonallelic genetic heterogeneity on 3q. Am J Hum Genet1993; 52: 319–26.
24.
PapadopoulosNNicolaidesNCWeiYF. Mutation of a mutL homolog in hereditary colon cancer. Science1994; 263: 1625–9.
25.
GyapayGMorrisetteJVignalA. The 1993–94 Genethon human genetic linkage map. Nat Genet1994; 7: 246–339.
26.
Gonzalez-ZuluetaMRuppertJMTokinoK. Microsatellite instability in bladder cancer. Cancer Res1993; 53: 5620–3.
27.
WeissenbachJGyapayGDibC. A second-generation linkage map of the human genome. Nature1992; 359: 794–801.
28.
CawkwellLLewisFAQuirkeP. Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction. Br J Cancer1994; 70: 813–8.
29.
WeberJLKwitekAEMayPE. Dinucleotide repeat polymorphisms at the D16S260, D16S261, D16S265, D16S266, and D16S267 loci. Nucleic Acids Res1990; 18: 4034.
30.
WeberJLKwitekAEMayPEWallaceMRCollinsFSLedbetterDH. Dinucleotide repeat polymorphisms at the D17S250 and D17S261 loci. Nucleic Acids Res1990; 18: 4640.
31.
TalbotCCJrAvramopoulosDGerkenS. The tetranucleotide repeat polymorphism D21S1245 demonstrates hypermutability in germline and somatic cells. Hum Mol Genet1995; 4: 1193–9.
32.
Dockhorn-DworniczakBDworniczakBBrommelkampLBullesJHorstJBockerWW. Non-isotopic detection of single strand conformation polymorphism (PCR-SSCP): A rapid and sensitive technique in diagnosis of phenylketonuria. Nucleic Acids Res1991; 19: 2500.
33.
HarrisAHSmithRR. Operative wound seeding with tumor cells: Its role in recurrences of head and neck cancer. Ann Surg1960; 151: 330–4.
WelshLW. The normal human laryngeal lymphatics. Ann Otol Rhinol Laryngol1964; 73: 569–82.
36.
ShahaARShahJP. Carcinoma of the subglottic larynx. Am J Surg1982; 144: 456–8.
37.
HongWKBromerRHAmatoDA. Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapy. Cancer1985; 56: 1242–5.
38.
DayGLBlotWJShoreRE. Second cancers following oral and pharyngeal cancers: Role of tobacco and alcohol. J Natl Cancer Inst1994; 86: 131–7.
39.
FrancoELKowalskiLPKandaJL. Risk factors for second cancers of the upper respiratory and digestive systems: A case-control study. J Clin Epidemiol1991; 44: 615–25.
40.
PartridgeMEmilionGPateromichelakisSPhillipsELangdonJ. Field cancerisation of the oral cavity: Comparison of the spectrum of molecular alterations in cases presenting with both dysplastic and malignant lesions. Oral Oncol1997; 33: 332–7.
41.
El NaggarAKHurrKHuffVClaymanGLLunaMABatsakisJG. Microsatellite instability in preinvasive and invasive head and neck squamous carcinoma. Am J Pathol1996; 148: 2067–72.
42.
ChungKYMukhopadhyayTKimJ. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res1993; 53: 1676–83.
